The Adaptogens Market exhibited a valuation of USD 10.7 billion in 2022, with a projected ascent to USD 18.38 billion by 2030. This growth is anticipated to manifest at a Compound Annual Growth Rate (CAGR) of 7% during the forecast period spanning from 2023 to 2030.